Patent 11135219 was granted and assigned to Nutech Ventures on October, 2021 by the United States Patent and Trademark Office.
This document relates to methods and materials for treating a mammal having a Zika virus (ZIKV) infection. For example, a composition including one or more non-nucleoside RNA polymerase inhibitors can be administered to a mammal having, or at risk of developing, a ZIKV infection to treat the mammal